CAR T-cell Therapy: Automated Production, Point-of-Care Approach

Arrow Down Icon


Subscribe Today
Description

In this episode, “CAR T-cell Therapy: Automated Production, POC Approach,” join Christopher Montalbano, CEO of MIDI, into the forefront of cancer treatment with this episode as we explore the transformative potential of CAR T-Cell Therapy and the revolutionary impact of Point-of-Care (POC) manufacturing. Discover how these advancements are poised to make this cutting-edge therapy more accessible and affordable for a broader patient population.

What You’ll Discover:

Why Tune In?

This episode offers a deep dive into the democratization of CAR T-Cell Therapy, highlighting how MIDI's automated closed-system instrument and disposable set present a revolutionary solution for cancer treatment. By addressing cost, contamination, and efficiency, this breakthrough approach promises to expand access to life-saving therapies for a larger patient population.

Stay Ahead in Cancer Treatment Innovations

Tune in to discover how POC manufacturing is set to transform the landscape of CAR T-Cell Therapy. Learn about the latest advancements that are bringing hope, healing, and accessible treatment options to millions of cancer patients.

Listen and be part of the conversation shaping the future of cancer care!

Stay informed about MIDI’s expanding capabilities,
new projects and our unique approach

Stay informed about MIDI’s expanding capabilities, new projects and our unique approach

We do not share your information with third parties

Our product experts can help bring your
innovation to market

Our product experts can help bring your innovation to market